Marketing Direct Mag - Spam Archive

Also in subscriptions.mhra.gov.uk

Regulatory Science in 2016 - Shaping the Future of Biological Medicines - Limited places available!


Regulatory Science in 2016 Shaping the Future of Biological Medicines

17th-18th May 2016

The Royal College of Obstetricians and Gynaecologists, London


Join the twitter conversation at #NIBSC40

This special event marks NIBSCs 40th anniversary. The symposium will provide a unique platform for cross-collaboration and discussion between industry, public sector, academia and regulators and focus on the latest thinking and opportunities arising from the new Biological Medicines.

The goal is to identify potential solutions, future work programmes and productive collaborations that overcome the key regulatory challenges and facilitate accelerated access to safe and effective biologicals.

We are delighted that Professor Dame Sally Davies, Chief Medical Officer, will be giving a keynote introductory address. The event will feature international and leading experts presenting on the four key scientific themes.

Click here to view Christian Schneider, Director of NIBSC,  talking about the Symposium event and benefits of attending. 

Third theme focusing on Keeping the vaccine pipeline flowing:

  • Vaccines of today and tomorrow
  • Vaccines, a renewed opportunity for our society
  • Can new vaccines help maintain a polio-free world after eradication?
  • Live viral vaccines, 1798-2016
  • Bacterial population genomics in the design, assessment and implementation of vaccines
  • Pharmacovigilance - a critical platform to support innovation


Speaker Line-up

 We are excited to announce the attendance of the following speakers to present this theme:

  • Professor Andrew Pollard - Director, Oxford Vaccine Group, University of Oxford
  • Professor Rino Rappuoli - Chief Scientist, GSK Vaccines
  • Dr Andrew Macadam - Principle Scientist, Virology, NIBSC
  • Dr Philip Minor - Deputy Director, NIBSC
  • Professor Martin Maiden - Professor of Molecular Epidemiology, University of Oxford
  • Dr Philip Bryan - Unit Manager, Vigilance and Risk Management, MHRA


Why attend?

  • Expected attendance of 200+ delegates from the biological medicines sector in the UK and abroad.
  • Learn about the latest strategic and technical developments taking place in biological medicines and gain insight into the regulatory challenge that they pose
  • Network and take the opportunity to meet key contacts, build relationships and initiate collaborations
  • Help shape the future of the new biological medicines regulation

There will also be the opportunity to pose questions, participate in technical discussions and to network with peers. The symposium networking dinner (included in ticket prices) will be held on the evening of the 17th May 2016.


Register now!

Who should attend?

This is must attend event for those who wish to help shape the future agenda of regulatory science for biological medicines.

The symposium will bring together world class leaders from:

  • Biologics manufacturers
  • Academics and Innovators
  • National and International Regulators and public health organisations
  • Policy makers and funding agencies

 

CPD-logo
 

© 2016 All content is available under the Open Government Licence v3.0, except where otherwise stated | .gov.uk email communications

Email gcs@cabinet-office.gsi.gov.uk | GCS - 020 7276 2295

Marketing Direct Mag - © Crown copyright | All printing supplied by PrintUK.com | Part of Spamdex - the spam archive for the internet

E-Marketing Madness

We have helpful advice from marketing experts across the globe, learn their tips and tricks and make your company more successful.